Pharmadrug Inc C.PHRX

Alternate Symbol(s): LMLLF

Medical Care Cannabis

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.

CSE:PHRX - Post by User

Pharmadrug Inc > Normal Course Action Likely Coming

<< Previous

Bullboard Posts

Next >>

Comment by Guytoruleon Aug 24, 2024 7:12pm

79 Views

Post# 36194906

RE:Normal Course Action Likely Coming

I Agree, possibility for sure..I also believe shortly some cash will come in with the purchase of more share of subsidiary Sairiyo by PharmaTher as per their financing agreement. Then a IPO completed successfully..I believe that alone could amount to $500k...and carry this company on G&A for a little while...we shall see..

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario